RespireRx Pharmaceuticals Inc (RSPI)

[laddadg]

This slow price decline is an exact duplicate of the pattern seen in March 2006 while anxiously awaiting the CX717 approval. The price shot down to the low 2's just before a very favorable outcome (and a rise to the high 5's).

There is no "logical" reason to believe that an unfavorable ruling will forthcoming on 10/11, but once again fear appears to be gaining momemtum. And like most of us, I too am getting the nervous nellies. JUST NOT ENOUGH TO CLOUD MY JUDGEMENT.

The most significant confirmation that CX717 will be given the go-ahead in October is that there were a large number of very wealthy, intelligent, savy investors who in late-August put up $14M of hard earned cash to purchase 7M shares at a price of $2/share.